NASDAQ
MBX Biosciences, Inc. Common Stock (MBX) has a current ratio of 24.62x as of Monday, May 25, 2026. This represents a 26.64% increase compared to its 12-month average of 19.44x. The current ratio measures a company's ability to cover short-term obligations by comparing current assets to current liabilities.
No price data available for this timeframe.